259 related articles for article (PubMed ID: 11995402)
1. [Safety and efficacy of total dose intravenous iron infusion in the treatment of iron-deficiency anemia in adult non-pregnant patients].
Reynoso-Gómez E; Salinas-Rojas V; Lazo-Langner A
Rev Invest Clin; 2002; 54(1):12-20. PubMed ID: 11995402
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of total dose infusion of low molecular weight iron dextran in the treatment of iron deficiency anemia during pregnancy.
Ayub R; Tariq N; Adil MM; Iqbal M; Junaid A; Jaferry T
J Coll Physicians Surg Pak; 2008 Jul; 18(7):424-7. PubMed ID: 18760066
[TBL] [Abstract][Full Text] [Related]
3. A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial.
Kulnigg S; Stoinov S; Simanenkov V; Dudar LV; Karnafel W; Garcia LC; Sambuelli AM; D'Haens G; Gasche C
Am J Gastroenterol; 2008 May; 103(5):1182-92. PubMed ID: 18371137
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of iron sucrose in patients sensitive to iron dextran: North American clinical trial.
Van Wyck DB; Cavallo G; Spinowitz BS; Adhikarla R; Gagnon S; Charytan C; Levin N
Am J Kidney Dis; 2000 Jul; 36(1):88-97. PubMed ID: 10873877
[TBL] [Abstract][Full Text] [Related]
5. Intravenous low molecular weight iron dextran in children with iron deficiency anemia unresponsive to oral iron.
Plummer ES; Crary SE; McCavit TL; Buchanan GR
Pediatr Blood Cancer; 2013 Nov; 60(11):1747-52. PubMed ID: 23832487
[TBL] [Abstract][Full Text] [Related]
6. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease--a randomized, controlled, open-label, multicenter study.
Schröder O; Mickisch O; Seidler U; de Weerth A; Dignass AU; Herfarth H; Reinshagen M; Schreiber S; Junge U; Schrott M; Stein J
Am J Gastroenterol; 2005 Nov; 100(11):2503-9. PubMed ID: 16279906
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of total dose infusion of iron dextran in iron deficiency anaemia.
Reddy CM; Kathula SK; Ali SA; Bekal R; Walsh M
Int J Clin Pract; 2008 Mar; 62(3):413-5. PubMed ID: 18005041
[TBL] [Abstract][Full Text] [Related]
8. A trial of two iron-dextran infusion regimens in chronic hemodialysis patients.
Agarwal R; Davis JL; Hamburger RJ
Clin Nephrol; 2000 Aug; 54(2):105-11. PubMed ID: 10968685
[TBL] [Abstract][Full Text] [Related]
9. A study for the evaluation of safety and tolerability of intravenous high-dose iron sucrose in patients with iron deficiency anemia due to gastrointestinal bleeding.
Schröder O; Schrott M; Blumenstein I; Jahnel J; Dignass AU; Stein J
Z Gastroenterol; 2004 Aug; 42(8):663-7. PubMed ID: 15314711
[TBL] [Abstract][Full Text] [Related]
10. Improving efficiency and value in health care. Intravenous iron management for anaemia associated with chronic kidney disease: linking treatment to an outpatient clinic, optimizing service provision and patient choice.
Bhandari S; Naudeer S
J Eval Clin Pract; 2008 Dec; 14(6):996-1001. PubMed ID: 18785894
[TBL] [Abstract][Full Text] [Related]
11. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
Li H; Wang SX
Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
[TBL] [Abstract][Full Text] [Related]
12. Supplementing iron intravenously in pregnancy. A way to avoid blood transfusions.
Hallak M; Sharon AS; Diukman R; Auslender R; Abramovici H
J Reprod Med; 1997 Feb; 42(2):99-103. PubMed ID: 9058345
[TBL] [Abstract][Full Text] [Related]
13. Intravenous versus oral iron for treatment of anemia in pregnancy: a randomized trial.
Al RA; Unlubilgin E; Kandemir O; Yalvac S; Cakir L; Haberal A
Obstet Gynecol; 2005 Dec; 106(6):1335-40. PubMed ID: 16319260
[TBL] [Abstract][Full Text] [Related]
14. Safety of total dose iron dextran infusion in geriatric patients with chronic kidney disease and iron deficiency anemia.
Dossabhoy NR; Turley S; Gascoyne R; Tapolyai M; Sulaiman K
Ren Fail; 2014 Aug; 36(7):1033-7. PubMed ID: 24845687
[TBL] [Abstract][Full Text] [Related]
15. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
Muneyyirci-Delale O; Richard-Davis G; Morris T; Armstrong J
Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549
[TBL] [Abstract][Full Text] [Related]
16. Treatment of iron deficiency anemia with intravenous iron preparations.
Akarsu S; Taskin E; Yilmaz E; Yilmaz H; Kilic M; Aygun AD
Acta Haematol; 2006; 116(1):51-7. PubMed ID: 16809890
[TBL] [Abstract][Full Text] [Related]
17. Accelerated total dose infusion of low molecular weight iron dextran is safe and efficacious in chronic kidney disease patients.
Sinha S; Chiu D; Peebles G; Swoboda P; Kolakkat S; Lamerton E; Fenwick S; Bhandari S; Kalra PA
QJM; 2011 Mar; 104(3):221-30. PubMed ID: 20956457
[TBL] [Abstract][Full Text] [Related]
18. Intravenous iron-dextran therapy in the treatment of anemia occurring in surgical, gynecologic and obstetric patients.
Mays T; Mays T
Surg Gynecol Obstet; 1976 Sep; 143(3):381-4. PubMed ID: 959957
[TBL] [Abstract][Full Text] [Related]
19. A comparative study between intramuscular iron dextran and oral ferrous sulphate in the treatment of iron deficiency anaemia in pregnancy.
Komolafe JO; Kuti O; Ijadunola KT; Ogunniyi SO
J Obstet Gynaecol; 2003 Nov; 23(6):628-31. PubMed ID: 14617464
[TBL] [Abstract][Full Text] [Related]
20. Parenteral iron dextran therapy: a review.
Burns DL; Mascioli EA; Bistrian BR
Nutrition; 1995; 11(2):163-8. PubMed ID: 7647482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
